Chinese police accuse 14 of selling second-hand medical devices; Global Orthopaedic Technology's hip implant wins 510(k);

@FierceMedDev: Elixir snags CE mark for dissolvable stent. News | Follow @FierceMedDev

@MarkHFierce: Roche won crucial FDA approval for a companion diagnostic for lung cancer. Goes with Astellas' Tarceva. Release | Follow @MarkHFierce

 @DamianFierce: Analogic is lopping off 140 jobs in Colorado and Vancouver. More | Follow @DamianFierce

> Patients implanted with pricey dual-chamber ICDs experienced no added benefits but suffered higher rates of complications than those fitted with single-chamber devices, according to a new study. Article

> Chinese police have arrested 14 people accused of selling smuggled, second-hand medical devices to clinics. Story

> Illumina ($ILMN) is teaming up with robotics makers to develop automation technology for its gene sequencing kits, announcing partnerships with Beckman Coulter Life Sciences, Eppendorf, Hamilton Robotics, PerkinElmer, and Tecan. News

> Agilent's ($A) diagnostics business, fueled by Dako, grew 124% last quarter, but the company's total revenue dropped 8% to $1.69 billion while net income fell about 45% to $166 million. Results

> Diagnostics outfit Sysmex signed a 5-year deal with the U.S. Department of Veterans Affairs to supply its XN-Series blood analyzers VA hospitals. More

> South Carolina and Israeli companies and universities will partner on a variety of R&D projects, likely including biomedical initiatives. Story

> Australia's Global Orthopaedic Technology gained the FDA's 510(k) clearance to market and sell its Paragon hip replacement system. Story

Biotech News

@FierceBiotech: $VVUS announces proposed offering of convertible senior notes. Release | Follow @FierceBiotech

@JohnCFierce: Quintiles joins Merck KGaA's R&D command post in 5-year exclusive. News | Follow @JohnCFierce

@RyanMFierce: Billionaires back Kite Pharma in $20M raise for cancer immunotherapies. Article | Follow @RyanMFierce

> FDA OKs pinpoint prostate cancer radiation drug Xofigo from Bayer, Algeta. News

> New crowdfunding platform set to launch new biotechs. More

> Tokai lands $35M venture round for triple-threat prostate cancer drug. News

Pharma News

@FiercePharma: ICYMI - execs' bogeymen: Animal-rights extremists, disease activists and laid-off workers, security tells FAA. Report | Follow @FiercePharma

> Roche wins new targeted OK for Tarceva in EGFR-positive lung cancer. News

> U.K. saves £1 million a day, thanks to generic Lipitor. News

> Actavis nixed a $15B offer from Mylan to zero in on Warner Chilcott . Article

Drug Delivery News

@MichaelGFierce: Israeli team spurs nerve healing with implant-released gel. More | Follow @MichaelGFierce

> New polymers shatter to release drugs at specific target. Report

> Marina platform to deliver first-ever miRNA cancer drug for Mirna PhI. News

> Scripps study reveals new RNA-drug targeting potential. Article

> FDA accepts Merck's sublingual allergy med license application. Item

Biomarkers News

> Genome mutations reveal acute myeloid leukemia risk, potential drug targets. Story

> Biomarker trio enables blood Dx to map heart attack risk. More

> Bristol-Myers Squibb, Adaptive Biotechnologies ally for cancer biomarker development. More

> Fetus secretes hormone that could flag preeclampsia risk. Article

> 9 blood-based biomarkers correspond to amyloid plaque in the brain. Item

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.